Approximately 80% of global cancer-related deaths occur in low and middle-income countries (LMICs), which might reflect poor access to oncology therapies, including drugs. Major breakthroughs have been realised in controlling cancer in the past five decades; however, for patients in low- and middle-income countries, many of these advances are nothing but an aspiration and hope for the future. Read more here.
Study mentioned: Lopes GD Jr, et al. Access to cancer medications in low- and middle-income countries. Nat Rev Clin Oncol. 2013 Apr 9. doi: 10.1038/nrclinonc.2013.55. [Epub ahead of print] PMID: 23568416
No comments:
Post a Comment